Glenview Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $357K | Buy |
5,107
+765
| +18% | +$53.5K | 0.01% | 406 |
|
|
2025
Q1 | $319K | Sell |
4,342
-71
| -2% | -$5.22K | 0.01% | 404 |
|
|
2024
Q4 | $289K | Sell |
4,413
-17
| -0.4% | -$1.11K | 0.01% | 420 |
|
|
2024
Q3 | $345K | Sell |
4,430
-1,222
| -22% | -$95.2K | 0.01% | 398 |
|
|
2024
Q2 | $441K | Buy |
5,652
+997
| +21% | +$77.8K | 0.01% | 368 |
|
|
2024
Q1 | $315K | Sell |
4,655
-122
| -3% | -$8.27K | 0.01% | 391 |
|
|
2023
Q4 | $322K | Buy |
4,777
+53
| +1% | +$3.57K | 0.01% | 392 |
|
|
2023
Q3 | $320K | Buy |
4,724
+174
| +4% | +$11.8K | 0.01% | 370 |
|
|
2023
Q2 | $326K | Buy |
4,550
+172
| +4% | +$12.3K | 0.01% | 374 |
|
|
2023
Q1 | $304K | Hold |
4,378
| – | – | 0.01% | 374 |
|
|
2022
Q4 | $297K | Buy |
4,378
+220
| +5% | +$14.9K | 0.01% | 368 |
|
|
2022
Q3 | $228K | Buy |
+4,158
| New | +$228K | 0.01% | 381 |
|
|
2021
Q4 | – | Sell |
-6,172
| Closed | -$371K | – | 416 |
|
|
2021
Q3 | $371K | Buy |
+6,172
| New | +$371K | 0.01% | 313 |
|
|
2013
Q4 | $358K | Buy |
+12,048
| New | +$358K | 0.04% | 164 |
|